CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in UTHR — UNITED THERAPEUTICS Corp

CIK 884546 SAN FRANCISCO, CA

Back to UTHR Full portfolio

Position in UTHR

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$178,179,223

+$36,912,780 QoQ

Shares Held

300,481

+3.6% QoQ

Ownership

0.708%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 99.9966720025559.ToString("F0")% Shared 0.ToString("F0")% None 0.0033279974440979633.ToString("F0")%

Common Shares in UTHR Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $1,628,257,886 across 43 Drug Manufacturers - Specialty & Generic names. UTHR ranks #3 (10.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	3,717,247	$439,415,767
2	VTRS	Viatris Inc	13,674,306	$184,739,874
3	UTHR	UNITED THERAPEUTICS Corp This page	300,481	$178,179,223
4	NBIX	Neurocrine Biosciences Inc	902,788	$118,933,291
5	ELAN	Elanco Animal Health Inc	3,577,850	$85,617,950
6	ALKS	Alkermes plc.	2,236,756	$79,091,692
7	TEVA	Teva Pharmaceutical Industries Ltd	2,087,679	$62,880,891
8	LNTH	Lantheus Holdings, Inc.	657,413	$49,864,776

All Filings in UTHR

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$178,179,223	300,481	+3.6%	Shares	Sole	2026-05-15
2025-12-31	$141,266,443	289,926	-7.4%	Shares	Sole	2026-02-13
2025-09-30	$131,190,931	312,948	-6.8%	Shares	Sole	2025-11-10
2025-06-30	$96,516,554	335,885	-4.3%	Shares	Sole	2025-08-12
2025-03-31	$108,158,995	350,858	-5.3%	Shares	Sole	2025-09-15
2024-12-31	$130,741,333	370,540	+0.2%	Shares	Sole	2025-02-06
2024-09-30	$132,573,374	369,955	-4.6%	Shares	Sole	2024-11-12
2024-06-30	$123,531,460	387,793	-2.7%	Shares	Sole	2024-08-12
2024-03-31	$91,528,947	398,437	+24.9%	Shares	Sole	2024-05-09
2023-12-31	$70,151,506	319,030	+2.5%	Shares	Sole	2024-02-06
2023-09-30	$70,314,912	311,307	-6.6%	Shares	Sole	2023-11-08
2023-06-30	$73,588,116	333,355	+6.2%	Shares	Sole	2023-08-10
2023-03-31	$70,329,934	314,029	+0.8%	Shares	Sole	2023-05-12
2022-12-31	$86,651,731	311,596	+4.1%	Shares	Sole	2023-02-13
2022-09-30	$62,686,068	299,389	-24.9%	Shares	Sole	2022-11-14
2022-06-30	$93,900,890	398,493	+1.7%	Shares	Sole	2022-08-15
2022-03-31	$70,297,682	391,827	+3.5%	Shares	Sole	2022-05-13
2021-12-31	$81,817,179	378,643	+1.4%	Shares	Sole	2022-02-11
2021-09-30	$68,900,945	373,285	+0.5%	Shares	Sole	2021-11-16
2021-06-30	$66,624,262	371,352	+1.2%	Shares	Sole	2021-08-16
2021-03-31	$61,355,974	366,808	+4.6%	Shares	Sole	2021-05-17
2020-12-31	$53,217,574	350,600	+2.3%	Shares	Sole	2021-02-16
2020-09-30	$34,621,083	342,783	-0.6%	Shares	Sole	2020-11-13
2020-06-30	$41,718,864	344,784	+2.8%	Shares	Sole	2020-08-20
2020-03-31	$31,804,464	335,384	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.